JP2018528208A - 放射線損傷からの保護のためのセコイソラリシレシノールジグルコシド（ｓｄｇ）および関連化合物の使用 - Google Patents

放射線損傷からの保護のためのセコイソラリシレシノールジグルコシド（ｓｄｇ）および関連化合物の使用 Download PDF

Info

Publication number
JP2018528208A
JP2018528208A JP2018511210A JP2018511210A JP2018528208A JP 2018528208 A JP2018528208 A JP 2018528208A JP 2018511210 A JP2018511210 A JP 2018511210A JP 2018511210 A JP2018511210 A JP 2018511210A JP 2018528208 A JP2018528208 A JP 2018528208A
Authority
JP
Japan
Prior art keywords
subject
sdg
aging
radiation
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018511210A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018528208A5 (enExample
Inventor
メルポ クリストフィドウ−ソロミドウ，
メルポ クリストフィドウ−ソロミドウ，
Original Assignee
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア, ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア filed Critical ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア
Publication of JP2018528208A publication Critical patent/JP2018528208A/ja
Publication of JP2018528208A5 publication Critical patent/JP2018528208A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2018511210A 2015-09-01 2016-08-31 放射線損傷からの保護のためのセコイソラリシレシノールジグルコシド（ｓｄｇ）および関連化合物の使用 Pending JP2018528208A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562212898P 2015-09-01 2015-09-01
US62/212,898 2015-09-01
PCT/US2016/049780 WO2017040718A1 (en) 2015-09-01 2016-08-31 USE OF SECOISOLARICIRESINOL DIGLUCOSIDES (SDGs) AND RELATED COMPOUNDS FOR PROTECTION AGAINST RADIATION DAMAGE

Publications (2)

Publication Number Publication Date
JP2018528208A true JP2018528208A (ja) 2018-09-27
JP2018528208A5 JP2018528208A5 (enExample) 2019-10-10

Family

ID=58188252

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018511210A Pending JP2018528208A (ja) 2015-09-01 2016-08-31 放射線損傷からの保護のためのセコイソラリシレシノールジグルコシド（ｓｄｇ）および関連化合物の使用

Country Status (10)

Country Link
US (1) US20180243327A1 (enExample)
EP (1) EP3344271A4 (enExample)
JP (1) JP2018528208A (enExample)
KR (1) KR20180041742A (enExample)
CN (1) CN108697748A (enExample)
AU (1) AU2016315952A1 (enExample)
CA (1) CA2997112A1 (enExample)
IL (1) IL257780A (enExample)
MA (1) MA45520A (enExample)
WO (1) WO2017040718A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3077034A1 (en) * 2017-09-27 2019-04-04 The Trustees Of The University Of Pennsylvania Use of secoisolariciresinol diglucosides (sdgs) and related compounds for protection against radiation-induced cardiovascular dysfunction

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09208461A (ja) * 1996-01-30 1997-08-12 Nisshin Oil Mills Ltd:The 活性酸素種消去剤及び退色防止剤
WO2002080702A1 (en) * 2001-04-04 2002-10-17 Unilever N.V. Use of lignans in foods
US20100239696A1 (en) * 2007-05-25 2010-09-23 The Trustees Of The University Of Pennsylvania Flaxseed lignan complex, methods of using amd compositions thereof
JP2013509277A (ja) * 2009-11-02 2013-03-14 プロキュア トリートメント センターズ インコーポレーテッド 小型アイソセントリックガントリ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351739B2 (en) * 2004-04-30 2008-04-01 Wellgen, Inc. Bioactive compounds and methods of uses thereof
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
US10045951B2 (en) * 2007-05-25 2018-08-14 The Trustees Of The University Of Pennsylvania Flaxseed lignan complex and its use thereof
WO2010017332A2 (en) * 2008-08-07 2010-02-11 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health & Human Services Radioprotectants targeting thrombospondin-1 and cd47
TR201815423T4 (tr) * 2013-06-10 2018-11-21 Scripps Research Inst (s,s)-sekoi̇zolari̇si̇resi̇nol di̇glukozi̇d ve (r,r)-sekoi̇zolari̇si̇resi̇nol di̇glukozi̇d'i̇n hazirlanmasi.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09208461A (ja) * 1996-01-30 1997-08-12 Nisshin Oil Mills Ltd:The 活性酸素種消去剤及び退色防止剤
WO2002080702A1 (en) * 2001-04-04 2002-10-17 Unilever N.V. Use of lignans in foods
US20100239696A1 (en) * 2007-05-25 2010-09-23 The Trustees Of The University Of Pennsylvania Flaxseed lignan complex, methods of using amd compositions thereof
JP2013509277A (ja) * 2009-11-02 2013-03-14 プロキュア トリートメント センターズ インコーポレーテッド 小型アイソセントリックガントリ

Also Published As

Publication number Publication date
MA45520A (fr) 2019-05-08
IL257780A (en) 2018-04-30
EP3344271A1 (en) 2018-07-11
US20180243327A1 (en) 2018-08-30
WO2017040718A1 (en) 2017-03-09
CA2997112A1 (en) 2017-03-09
AU2016315952A1 (en) 2018-04-05
EP3344271A4 (en) 2019-05-08
CN108697748A (zh) 2018-10-23
KR20180041742A (ko) 2018-04-24

Similar Documents

Publication Publication Date Title
EP2935215B1 (en) Radiosensitizer compounds for use in combination with radiation
Cherdyntseva et al. Effect of tocopherol-monoglucoside (TMG), a water-soluble glycosylated derivate of vitamin E, on hematopoietic recovery in irradiated mice
CN110934879B (zh) 靶向组织微环境中衰老细胞的抗衰老药物d/a及其应用
JP2014201591A (ja) 医用画像処理電離放射線被曝の長期的および短期的な有害な影響をゲニステインの投与により軽減する方法
JPH07505608A (ja) インターロイキン−１阻害化合物による神経病学的状態の治療
JP2018528208A (ja) 放射線損傷からの保護のためのセコイソラリシレシノールジグルコシド（ｓｄｇ）および関連化合物の使用
RU2485956C2 (ru) Новая композиция для лечения побочных эффектов противораковой терапии
US10639296B2 (en) Methods to mitigate injury from radiation exposure
WO2014106473A1 (zh) 甘草次酸、甘草酸在制备预防或治疗放射性软组织损伤药物中的应用
EP3998084A1 (en) Cancer cell-targeted drug delivery carrier and composition for promoting photo-thermal treatment effects, both of which contain m1 macrophages as active ingredient
JP7144052B2 (ja) 掻痒性皮膚疾患の予防又は治療薬
HK1262581A1 (en) USE OF SECOISOLARICIRESINOL DIGLUCOSIDES (SDGs) AND RELATED COMPOUNDS FOR PROTECTION AGAINST RADIATION DAMAGE
TW201341352A (zh) 用於治療癌症轉移之方法和組合物
WO2017173308A1 (en) Radiation mitigator and method of use thereof
US11318161B2 (en) Methods of treating basal cell carcinoma and glioblastoma
CN110664817B (zh) 铁调素拮抗剂ldn193189及其衍生物在制备药物中的应用
CN114081880B (zh) 木香内酯及其衍生物在制备预防和/或治疗肠损伤的药物中的用途
US20200268779A1 (en) USE OF SECOISOLARICIRESINOL DIGLUCOSIDES (SDGs) AND RELATED COMPOUNDS FOR PROTECTION AGAINST RADIATION-INDUCED CARDIOVASCULAR DYSFUNCTION
EP3925611A1 (en) Radiosensitizer
RU2307398C2 (ru) Способ физико-биологической профилактики острой лучевой болезни
RU2119805C1 (ru) Способ лечения энцефалопатии
KR20200137294A (ko) 플로로탄닌을 포함하는 방사선에 의한 피부질환 예방, 개선 또는 치료용 조성물
JP2018528208A5 (enExample)
WO2024059829A1 (en) Compositions and methods for protecting salivary glands from off-target radiation damage
Flisser et al. Effect of praziquantel on the migration and survival of developmental stages of Schistosoma mansoni in mice

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190830

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190830

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200720

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20201019

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20210319